Professor Jack Wong, Associate Professor at the School of Life Sciences of The Chinese University of Hong Kong (CUHK) and Co-Founder of NutrigeneAI Biotech Limited, has recently been featured in major Hong Kong media, including the Hong Kong Economic Times, Sing Tao Daily, Wen Wei Po, HK01, and the South China Morning Post. These reports highlighted NutrigeneAI’s pioneering development of a first-in-class vascular regeneration drug designed to prevent amputations in patients with diabetic foot ulcers and peripheral artery disease (PAD).